Should you buy NEO stock?
Last updated:
Based on market data through , StockInvest.us rates NeoGenomics (NEO) as a Strong Buy Candidate with a technical score of 6.39 on its -10 to +10 scale. This is an upgrade from Buy in the previous daily evaluation.
- Buy signal since
- Price since signal Up 24.10%
- 3-month trend forecast Up 79.60%
- +185.7% price growth over the last year
- Consistently positive technical signals over the last month
- +41.4% YTD performance
Stronger technical forecast for NeoGenomics stock price after Monday trading
(Market data through Aug 10, 2026)
The NeoGenomics stock price gained 0.362% on the last trading day (Monday, 10th Aug 2026), rising from $16.57 to $16.63. During the last trading day the stock fluctuated 3.64% from a day low at $16.34 to a day high of $16.93. The price has risen in 7 of the last 10 days and is up by 26.56% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 707 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $32.36 million.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 79.60% during the next 3 months and, with a 90% probability hold a price between $25.97 and $33.15 at the end of this 3-month period.
NEO Signals & Forecast
Mostly positive signals in the chart today. The NeoGenomics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $15.99 and $14.51. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, July 27, 2026, and so far it has risen 26.56%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.
Support, Risk & Stop-loss for NeoGenomics stock
On the downside, the stock finds support just below today's level from accumulated volume at $15.27 and $14.61. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, NeoGenomics finds support just below today's level at $15.27. If this is broken, then the next support from accumulated volume will be at $14.61 and $14.17.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.595 between high and low, or 3.64%. For the last week, the stock has had daily average volatility of 3.98%.
Our recommended stop-loss: $16.01 (-3.72%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 10 days ago.)
Trading Expectations (NEO) For The Upcoming Trading Day Of Tuesday 11th
For the upcoming trading day on Tuesday, 11th we expect NeoGenomics to open at $16.63, and during the day (based on 14 day Average True Range), to move between $16.23 and $17.03, which gives a possible trading interval of +/-$0.81 (+/-4.99%) up or down from last closing price. If NeoGenomics takes out the full calculated possible swing range there will be an estimated 4.99% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ $15.27, some $1.36 (8.18%) from the current price of $16.63, our system finds the risk reward attractive.
Is NeoGenomics stock A Buy?
NeoGenomics holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.
Current score:
6.390
Strong Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on August 11, 2026 - $16.63 ( 0.0100%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
NEO Performance
Trading levels for NEO
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 17.23 | 3.59% |
| R2 | 17.00 | 2.22% |
| R1 | 16.86 | 1.38% |
| Price | 16.63 | |
| S1 | 16.40 | -1.36% |
| S2 | 16.26 | -2.20% |
| S3 | 16.04 | -3.57% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 0 | - |
| Price | 16.63 | |
| S1 | 15.27 | -8.18% |
| S2 | 14.61 | -12.15% |
| S3 | 14.17 | -14.79% |
NEO Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Dec 15, 2020 | Dec 17, 2020 | Dec 30, 2020 | $0.400 | 0.738% |
FAQ
Click here for our free guide on how to buy NeoGenomics Stock.
Buy NEO